top of page
Phage Discovery Engine
As antimicrobial resistance continues to rise worldwide, bacteriophages offer a targeted approach to controlling harmful bacteria. Lysentra is supplying scientific resources that can help accelerate research, product development, and future bacteriophage-based innovations. Lysentra is building a diverse bacteriophage library to support innovation across multiple fields.
Antimicrobial Resistance • Targeted Bacterial Control • Phage Characterization •
Why Lysentra?
Global Need
Antimicrobial resistance is one of the world's fastest growing public health challenges.
Scientific Expertise
Founded by an experienced microbiologist specializing in bacteriophage discovery and assay development.
Multiple Markets
Healthcare • Food Safety • Agriculture • Research • Industrial Applications
Scalable Platform
Building a proprietary bacteriophage library with applications across multiple industries.
We are at the forefront of a global health revolution. With the global AMR market projected to exceed $150 billion by 2030, our precision discovery platform offers a high-growth opportunity to lead the next generation of antibacterial solutions.
bottom of page